论文部分内容阅读
目的探讨脑苷肌肽辅助治疗老年脑梗死患者的疗效。方法 60例老年脑梗死患者作为研究对象,根据治疗方法不同将患者分为辅助组和常规组,每组30例。辅助组患者给予脑苷肌肽辅助常规治疗,常规组给予常规治疗。对比两组患者的治疗效果。结果两组患者治疗前斯坎迪纳维亚神经卒中量表(SNSS)评分比较差异无统计学意义(P>0.05),辅助组患者经治疗后SNSS评分(11.6±1.5)分低于常规组的(17.9±1.8)分,差异具有统计学意义(P<0.05)。辅助组患者治疗总有效率93.3%高于常规组的73.3%,差异具有统计学意义(P<0.05)。结论脑苷肌肽辅助治疗能改善脑梗死患者神经功能缺损状况,可在老年脑梗死患者的治疗中推广使用。
Objective To investigate the therapeutic effect of cerebroside on elderly patients with cerebral infarction. Methods Sixty elderly patients with cerebral infarction were selected as study subjects. According to the different treatment methods, the patients were divided into auxiliary group and conventional group, 30 cases in each group. Patients in the adjuvant group were given cerebroside-aided conventional therapy, while those in the routine group were given conventional therapy. Compare the treatment effect of two groups of patients. Results There was no significant difference in SNSS scores between the two groups before treatment (P> 0.05). The score of SNSS in the auxiliary group (11.6 ± 1.5) was lower than that of the conventional group (17.9 ± 1.8) points, the difference was statistically significant (P <0.05). The total effective rate of the auxiliary group was 93.3% higher than that of the conventional group (73.3%), the difference was statistically significant (P <0.05). Conclusion Cerebroside-a-carnosine adjuvant therapy can improve the neurological deficits in patients with cerebral infarction and can be used in the treatment of elderly patients with cerebral infarction.